1 completed, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow Edoardo Melilli: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response Switch from Mycophenolate Mofetil to Everolimus manteinance treatment in Active Comparator Arm, no intervention - Kidney Transplantation, Cytomegalovirus Infections | Phase 4 | Withdrawn | Edoardo Melilli | 2021-09-01 | 2024-02-28 | |
| Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants Everolimus, Mycophenolate mofetil, Tacrolimus - Hypertrophy, Left Ventricular | Phase 4 | Completed | Edoardo Melilli | 20 | 2016-11-01 | 2021-01-08 |
Cytomegalovirus Infections (1) · Hypertrophy, Left Ventricular (1)
Everolimus (1) · Mycophenolic Acid (1) · Tacrolimus (1)
Spain (2)